PRIVACY POLICY

COOKIE POLICY

CONTACT

PRESS RELEASES

ADVERTISE

SIGN UP

CONTACT

MEDICAL DEVICE NEWS MAGAZINE

Past News

Viome Life Sciences Raises $54M

"Viome is rapidly scaling to become a global leader in the longevity space, to promote better health outcomes today and our future generations, with exceptional innovation," said Harish Consul, Founder & CEO, Ocgrow Ventures. 

PureTech Receives Approximately $100 Million from Sale of a Portion of Founded Entity Shares

PureTech intends to use the proceeds from the Transaction to further the advancement and growth of the Company and will update its cash runway guidance in due course.

Syncona leads $87 MSeries A Financing of Clade Therapeutics, New Cell Therapy Company

Syncona led the financing round alongside specialist investors including LifeSci Ventures, Emerson Collective, and global biopharmaceutical company Bristol Myers-Squibb.

Vensica Therapeutics Closes $16 Million Investment Round

Vensica Therapeutics a clinical stage biopharmaceutical company, announced that it has closed an investment round of $16 million. The investment round was led by Israel Biotech Fund ("IBF"), a venture fund investing in Israeli and Israeli-related biotechnology and pharmaceutical...

Palette Life Sciences Secures Loan Facility for Up to $40 Million with Silicon Valley Bank

James Leech, VP of Strategy & Corporate Development at Palette Life Sciences, stated “This debt financing provides Palette Life Sciences with considerable flexibility as we continue to expand upon our revenue generation and geographic footprint, including the sale of our exciting organ spacing product, Barrigel. The team can focus 100% of its resources on critical commercial and operational activities across the business.”

Sequential Skin Raise US $1.65M in Oversubscribed Seed Round

This latest investment brings the total venture funding raised by Sequential Skin to US $2.15M in 2021.

NeuroBo Pharmaceuticals Closes $14 Million Registered Direct Offering

H.C. Wainwright & Co. acted as the exclusive placement agent for the offering

54gene Closes $25M Series B

The round also included participation from Adjuvant Capital, KdT Ventures, Plexo Capital, Endeavor Capital, Ingressive Capital and others.

Vanqua Bio Launches with $85 Million Series B Financing and a Mission to Vanquish Neurodegenerative Diseases

Novel drug-development approach combines advanced insights into critical neuronal cell pathways with cutting-edge assays to enable next-generation therapies.

Cytovia Therapeutics and its Newly Formed China-Focused CytoLynx Joint Venture Raise $45 Million to Advance NK Cell Therapy Pipeline

Cytovia eligible for up to $400 million in licensing milestones for Greater China rights.vCoordinated US and China clinical development of GPC3-targeted therapies for hepatocellular carcinoma.

Locate Bio Closes £10 million Funding Round

Investors include Mercia Asset Management and BGF. Funding to further advance Locate Bio’s regenerative medicine pipeline of orthobiologics

Immunitas Therapeutics Completes $58 Million Series B Financing

Funding to advance novel NK and T cell modulator IMT-009 for the treatment of solid tumor and hematological cancers with an anticipated IND filing in 1H 2022.
spot_img

Latest News

Dr. Anne Beal Is Appointed to the BOD of Prolacta Bioscience

"Anne's extensive experience in healthcare as a physician and entrepreneur is well recognized and respected," said Scott Elster, CEO of Prolacta.

Arctic Vision Announces First Patient Dosed in Phase III Study of ARVN001 for Treatment of Macular Edema Associated with Uveitis (UME)

The leading principal investigator of the Phase III study of ARVN001 is Professor Peizeng Yang, an uveitis expert in China.

Connect Biopharma Expands Executive Leadership Team with Hire of Steven Chan as CFO

Mr. Chan joins Connect from Delphon Industries LLC, a global materials manufacturer for the semiconductor, photonics, electronics and medical industries based in Hayward, California where he served as Chief Financial Officer and led its finance, human resources and legal functions.

Aditum Bio Announces Formation of Motric Bio

Motric Bio is the seventh company formed by Aditum Bio.

Join Medical Device News Magazine's Mailing List: Receive a Weekly Recap of Device Industry News

spot_img